BRIEF-Monopar Announces Abstract Accepted With Distinction For Oral And Poster Presentations At The Upcoming American Neurological Association 2025 Annual Meeting

Reuters
Sep 03
BRIEF-Monopar Announces Abstract Accepted With Distinction For Oral And Poster Presentations At The Upcoming American Neurological Association 2025 Annual Meeting

Sept 3 (Reuters) - Monopar Therapeutics Inc MNPR.O:

  • MONOPAR ANNOUNCES ABSTRACT ACCEPTED WITH DISTINCTION FOR ORAL AND POSTER PRESENTATIONS AT THE UPCOMING AMERICAN NEUROLOGICAL ASSOCIATION 2025 ANNUAL MEETING

Source text: ID:nGNX8ts4x8

Further company coverage: MNPR.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10